Cargando…

What are the statistical implications of treatment non‐compliance in cluster randomized trials: A simulation study

Subjects in randomized controlled trials do not always comply to the treatment condition they have been assigned to. This may cause the estimated effect of the intervention to be biased and also affect efficiency, coverage of confidence intervals, and statistical power. In cluster randomized trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Moerbeek, Mirjam, van Schie, Sander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856967/
https://www.ncbi.nlm.nih.gov/pubmed/31578760
http://dx.doi.org/10.1002/sim.8351
_version_ 1783470679180443648
author Moerbeek, Mirjam
van Schie, Sander
author_facet Moerbeek, Mirjam
van Schie, Sander
author_sort Moerbeek, Mirjam
collection PubMed
description Subjects in randomized controlled trials do not always comply to the treatment condition they have been assigned to. This may cause the estimated effect of the intervention to be biased and also affect efficiency, coverage of confidence intervals, and statistical power. In cluster randomized trials non‐compliance may occur at the subject level but also at the cluster level. In the latter case, all subjects within the same cluster have the same compliance status. The purpose of this study is to investigate the statistical implications of non‐compliance in cluster randomized trials. A simulation study was conducted with varying degrees of non‐compliance at either the cluster level or subject level. The probability of non‐compliance depends on a covariate at the cluster or subject level. Various realistic values of the intraclass correlation coefficient and cluster size are used. The data are analyzed by intention to treat, as treated, per protocol and the instrumental variable approach. The results show non‐compliance may result in downward biased estimates of the intervention effect and an under‐ or overestimate of its standard deviation. The coverage of the confidence intervals may be too small, and in most cases, empirical power is too small. The results are more severe when the probability of non‐compliance increases and the covariate that affects compliance is unobserved. It is advocated to avoid non‐compliance. If this is not possible, compliance status and covariates that affect compliance should be measured and included in the statistical model.
format Online
Article
Text
id pubmed-6856967
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68569672019-11-21 What are the statistical implications of treatment non‐compliance in cluster randomized trials: A simulation study Moerbeek, Mirjam van Schie, Sander Stat Med Research Articles Subjects in randomized controlled trials do not always comply to the treatment condition they have been assigned to. This may cause the estimated effect of the intervention to be biased and also affect efficiency, coverage of confidence intervals, and statistical power. In cluster randomized trials non‐compliance may occur at the subject level but also at the cluster level. In the latter case, all subjects within the same cluster have the same compliance status. The purpose of this study is to investigate the statistical implications of non‐compliance in cluster randomized trials. A simulation study was conducted with varying degrees of non‐compliance at either the cluster level or subject level. The probability of non‐compliance depends on a covariate at the cluster or subject level. Various realistic values of the intraclass correlation coefficient and cluster size are used. The data are analyzed by intention to treat, as treated, per protocol and the instrumental variable approach. The results show non‐compliance may result in downward biased estimates of the intervention effect and an under‐ or overestimate of its standard deviation. The coverage of the confidence intervals may be too small, and in most cases, empirical power is too small. The results are more severe when the probability of non‐compliance increases and the covariate that affects compliance is unobserved. It is advocated to avoid non‐compliance. If this is not possible, compliance status and covariates that affect compliance should be measured and included in the statistical model. John Wiley and Sons Inc. 2019-10-03 2019-11-20 /pmc/articles/PMC6856967/ /pubmed/31578760 http://dx.doi.org/10.1002/sim.8351 Text en © 2019 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Moerbeek, Mirjam
van Schie, Sander
What are the statistical implications of treatment non‐compliance in cluster randomized trials: A simulation study
title What are the statistical implications of treatment non‐compliance in cluster randomized trials: A simulation study
title_full What are the statistical implications of treatment non‐compliance in cluster randomized trials: A simulation study
title_fullStr What are the statistical implications of treatment non‐compliance in cluster randomized trials: A simulation study
title_full_unstemmed What are the statistical implications of treatment non‐compliance in cluster randomized trials: A simulation study
title_short What are the statistical implications of treatment non‐compliance in cluster randomized trials: A simulation study
title_sort what are the statistical implications of treatment non‐compliance in cluster randomized trials: a simulation study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856967/
https://www.ncbi.nlm.nih.gov/pubmed/31578760
http://dx.doi.org/10.1002/sim.8351
work_keys_str_mv AT moerbeekmirjam whatarethestatisticalimplicationsoftreatmentnoncomplianceinclusterrandomizedtrialsasimulationstudy
AT vanschiesander whatarethestatisticalimplicationsoftreatmentnoncomplianceinclusterrandomizedtrialsasimulationstudy